AMGEN ANNOUNCES POSITIVE TOPLINE PHASE 3 RESULTS FOR SUBCUTANEOUS TEPEZZA® IN ADULTS LIVING WITH MODERATE-TO-SEVERE ACTIVE THYROID EYE DISEASE

Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Pr...

IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer

Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low...

biogen report first quarter 2026 financial results april 29 2026

4/6/2026Press ReleaseAgios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ETRead More

Transforming High-Quality Care at East Campus Medical Center

Canada's Yukon Territory publishes First Nations Cancer Strategy

European Breast Cancer Conference 2026

Senators demand explanation for US Preventive Services Task Force halt

Immunogenicity of high-dose recombinant influenza vaccine versus standard-dose egg-grown and cell-grown vaccines among frequently and infrequently vaccinated young adults in Singapore: a randomised, controlled, double-blind, single-centre, phase 4 clinical trial

Concerns regarding study of spatial emanators for malaria control

Concerns regarding study of spatial emanators for malaria control - Authors' reply

Percutaneous coronary intervention versus coronary artery bypass grafting for unprotected left main stenosis: 10-year final results from the randomised, open-label, non-inferiority NOBLE trial

Global burden of cancer in children and adolescents aged 0-19 years, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

Perioperative immunotherapy for resectable hepatocellular carcinoma - Authors' reply

Perioperative immunotherapy for resectable hepatocellular carcinoma

Clinical phenotyping improves choices of biologics in asthma - Authors' reply

Clinical phenotyping improves choices of biologics in asthma

China’s past cinnabar use left a mercury signature written in human bone

Washington University School of Medicine

Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

The Democratization of Care: Scaling the Artisan Surgeon through Physical AI

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity

Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a c...

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause

FDA adds warning about rare occurrence of serious liver injury with use of Veozah (fezolinetant) for...

FDA adds Boxed Warning about a rare but serious allergic reaction called anaphylaxis with the multiple sclerosis medicine glatiramer acetate (Copaxone, Glatopa)

FDA adds Boxed Warning about a rare but serious allergic reaction called anaphylaxis with the multip...

FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medicines cetirizine or levocetirizine (Zyrtec, Xyzal, and other trade names)

FDA requires warning about rare but severe itching after stopping long-term use of oral allergy medi...

FDA adds warning about serious risk of heat-related complications with antinausea patch Transderm Scōp (scopolamine transdermal system)

The antinausea patch Transderm Scōp (scopolamine transdermal system) can increase body temperature a...

FDA is requiring opioid pain medicine manufacturers to update prescribing information regarding long-term use

FDA is requiring safety labeling changes for opioid pain medicines to further emphasize and characte...

FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozapine

FDA removes risk evaluation and mitigation strategy (REMS) program for the antipsychotic drug Clozap...

FDA to recommend additional, earlier MRI monitoring for patients with Alzheimer’s disease taking Leqembi (lecanemab)

FDA to recommend additional, earlier MRI monitoring for patients with Alzheimer’s disease taking Leq...

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor Agonist (GLP-1 RA) Medications

FDA Requests Removal of Suicidal Behavior and Ideation Warning from Glucagon-Like Peptide-1 Receptor...

FDA Is Requiring Warning about Vitamin B6 Deficiency and Associated Seizures for Drug Products Containing Carbidopa/Levodopa

FDA has notified application holders for all drug products containing carbidopa/levodopa that the Ag...

FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active Anti-neutrophil Cytoplasmic Autoantibody (ANCA)-associated Vasculitis

FDA Identifies Cases of Serious Liver Injury in Patients Taking Tavneos (avacopan) for Severe Active...

Generic Drug User Fee Amendments

This page features news and information for industry and stakeholders about GDUFA, its fee structure...

As They Grow: Teaching Your Children How To Use Medicines Safely

How to start talking to your children about medicines and how you make medicine decisions for yourse...

FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan)

Stay informed on FDA updates and press announcements about recalls involving angiotensin II receptor...

Stop - Learn - Go: Tips for Talking with Your Pharmacist to Learn How to Use Medicines Safely

Points to discuss with your pharmacist and other healthcare providers

FDA Rare Disease Innovation Hub

FDA created the Rare Disease Innovation Hub (the Hub) to serve as a point of collaboration and conne...

FDA Issues Draft Guidance for Industry on the Design and Evaluation of Comparative Analytical Studies for Biosimilarity

CDER Statement

Lee Shapiro on Data-driven Preventative Medicine and the Fight against “Sick Care”

Cinglan 30 mg-Filmtabletten

Rückruf aufgrund verminderter Wirkstofffreisetzung

Intravenous immunoglobulin treatment for long COVID: a case report of clinical and immunological findings

The case for routine patient review in long COVID research

Erratum: Tissue-Free Circulating Tumor DNA Assay and Patient Outcome in a Phase III Trial of FOLFOX-Based Adjuvant Chemotherapy (Alliance N0147)

SEQENS to launch PeptiCode™ HP-9: the first European biotech Hexapeptide-9

Menicon Renames Its Sales Subsidiaries in Malaysia and Indonesia – Promoting Brand Integration and Business Expansion in Southeast Asia –

Join IceCure at ASBrS 2026: Cryoablation for Breast Cancer in Low-Risk Patients

Regeneron Collaborates with TriNetX to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

Preclarus lab data ecosystem: Delivering complete visibility and confidence across every lab partner

CMIC HOLDINGS Announces Changes to Management Structure

KBI Biopharma Named Fill-Finish CDMO of the Year and Best in Class for Cultural Fit in 2026 CDMO Leadership Awards

Health Chief Warns of “Triple Trouble” as doctors’ strike follows Easter holiday

From Data to Compliance: Key Elements of IMPD and CTA Preparation

Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York

UCLH recruits first European participant to advanced-phase lung cancer trial

Signant Health Appoints Dr. Graham C. Ellis as Clinical Vice President

Research from Rowitch and collaborators uncovers vulnerable brain cells prone to DNA damage in development and Multiple Sclerosis (MS)

Prof. Rüdiger Zimmerer übernimmt Leitung der MKG-Klinik an der Universitätsmedizin Essen

The tumor microbiota: a new frontier in cancer biology

Resident doctor industrial action